Agilent Technologies Inc. (A)

About Agilent Technologies Inc.

Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 1,101 institutions reported holding A, with 258.2 million shares worth $34.3 billion in aggregate. The largest reported holders were Vanguard, BlackRock and State Street. Of the 5 largest reported holders, 2 added shares and 3 reduced their positions during the quarter.

More on A

• A sentiment: whether news and social coverage of Agilent Technologies Inc. leans bullish or bearish, and the stories driving it.
• A ownership: all 1,101 reporting institutions, plus insider and congressional trades.
• A financials: revenue, net income, operating margin and free cash flow by quarter and year.

SentiSense also tracks daily options readings for Agilent Technologies Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions